Area of Research: BRCA Mutations

2021 Grant Recipients

• Anup Singh, PhD, La Jolla Institute for Immunology
  Ann and Sol Schreiber Mentored Investigator Award
  Studying the Role of BRCA1 in Regulating Heterochromatin Structure and Function in Ovarian Cancer

2020 Grant Recipients

• Morozov Yaroslav, PhD, University of Pennsylvania
  Ann and Sol Schreiber Mentored Investigator Award
  The BRCA1-A as a Determinant of Chemotherapy Response in ATM Mutated Cells

2019 Grant Recipients

• John Krais, PhD, Fox Chase Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Examining the Role of RNF168 in BRCA1 Mutant Ovarian Cancer
• Zihua Gong, MD, PhD, Cleveland Clinic
  Liz Tilberis Early Career Award
  DNA Repair Pathways as Targets for Therapy-Resistant Ovarian Cancer

2018 Grant Recipients

• Shih-Hsun Chen, PhD, Beckman Research Institute of the City of Hope
  Ann and Sol Schreiber Mentored Investigator Award
  Targeting de-poly (ADP-ribosyl)ation for Ovarian Cancer Therapy
• Katherine Fuh, MD, PhD, Washington University in St. Louis
  Liz Tilberis Early Career Award
  Inhibition of Metastasis in BRCA2-associated Ovarian Cancers
• Jian Yuan, PhD, Mayo Clinic
  Liz Tilberis Early Career Award
  The Role of BRD9-Rad51 Axis in Chemoresistance in Ovarian Cancer

2017 Grant Recipients

• Priyanka Verma, PhD, University of Pennsylvania
  Ann and Sol Schreiber Mentored Investigator Award
  BRCA-Independent DNA Repair Pathways in Ovarian Cancer

2016 Grant Recipients

• Nur Yucer, PhD, Cedars-Sinai Medical Center
  Ann and Sol Schreiber Mentored Investigator Award
  Modeling Mullarian HGSC Using BRCA1 Patient Derived iPSCs
• Alberto Ciccia, PhD, Columbia University Medical Center
  Liz Tilberis Early Career Award
  Defining the Molecular Mechanisms of BRCA1-dependent Tumor Suppression
• Zihua Gong, MD, PhD, MD Anderson Cancer Center
  Liz Tilberis Early Career Award
  DNA Repair Pathways as Target for Therapy-Resistant Ovarian Cancer

2015 Grant Recipients

• Petar Jelinic, PhD, Memorial Sloan Kettering Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  EMSY Suppresses HDR in a BRCA2-interaction-independent Manner
• Sarah Adams, MD, University of New Mexico
  Liz Tilberis Early Career Award
  A Combination Therapy for Hereditary Ovarian Cancer

2014 Grant Recipients

• Ryan B. Jensen, PhD, Yale University
  Liz Tilberis Early Career Award
  A Cellular Switch to Modulate BRCA2-mediated Tumor Progression
• Ronen Marmorstein, PhD, University of Pennsylvania
  Collaborative Research Development Grant
  Chromatin Regulatory Mechanisms in Ovarian Cancer

2012 Grant Recipients

• Melinda Yates, PhD, MD Anderson Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Unraveling the Initiation of Ovarian Cancer: The BRCA1-Heterozygous Mouse as a Model System

2011 Grant Recipients

• Sarah Adams, MD, University of Pennsylvania
  Liz Tilberis Early Career Award
  Development of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer

2007 Grant Recipients

• Qin Yang, MD, PhD, University of Washington
  Individual Investigator Award
  BRCA/AKT1 Pathway in Ovarian Cancer

2005 Grant Recipients

• Xiaochun Yu, MD, PhD, University of Michigan
  Individual Investigator Award
  How Hereditary and Non-Hereditary Cancer May Have Something in Common

2004 Grant Recipients

• Wael El Shamy, PhD, Dana Farber Cancer Institute
  Individual Investigator Award
  Another Protein Made by BRCA1 and its Role in Ovarian Cancer